The delivery of the diphtheria toxin catalytic domain (DTA) from acidified endosomes into the cytoplasm of eukaryotic cells requires protein-protein interactions between the toxin and a cytosolic translocation factor (CTF) complex. A conserved peptide motif, T1, within the DT transmembrane helix 1 mediates these interactions. Because the T1 motif is also present in the N-terminal segments of lethal factor (LF) and edema factor (EF) in anthrax toxin, we asked whether LF entry into the cell might also be facilitated by target cell cytosolic proteins. In this study, we have used LFnDTA and its associated ADP-ribosyltransferase activity (DTA) to determine the requirements for LF translocation from the lumen of endosomal vesicles to the external medium in vitro. Although low-level release of LFnDTA from enriched endosomal vesicles occurs in the absence of added factors, translocation was enhanced by the addition of cytosolic proteins and ATP to the reaction mixture. We show by GST-LFn pull-down assays that LFn specifically interacts with at least -COP and -COP of the COPI coatomer complex. Immunodepletion of COPI coatomer complex and associated proteins from cytosolic extracts blocks in vitro LFnDTA translocation. Translocation may be reconstituted by the addition of partially purified bovine COPI to the translocation assay mixture. Taken together, these data suggest that the delivery of LF to the cytosol requires either COPI coatomer complex or a COPI subcomplex for translocation from the endosomal lumen. This facilitated delivery appears to use a mechanism that is analogous to that of DT entry. diphtheria toxin ͉ anthrax toxin R eceptor-mediated endocytosis of many bacterial protein toxins ensures their passage through an acidified endosomal compartment. Diphtheria toxin (DT), anthrax toxin (AT), and the botulinum neurotoxins all require exposure to a low-pH environment for the delivery of their respective catalytic domains to the cytosol (1-3). In the case of DT, exposure to a low-pH environment is known to trigger a dynamic change in the transmembrane domain resulting in its spontaneous insertion into the vesicle membrane and the formation of a pore or channel (1). Ratts et al. (4) have demonstrated that the in vitro translocation of the DT catalytic domain from the lumen of partially purified endosomal vesicles through this pore to the external milieu requires the addition of ATP and a cytosolic translocation factor (CTF) complex to the in vitro translocation assay mixture (4). Although the CTF complex has not been fully characterized, several components including Hsp90, thioredoxin reductase, and -COP from the COPI coatomer complex have been shown to be essential components in the catalytic domain delivery process (4-6).Subsequently, Ratts et al. (5) described a putative translocation motif, T1, in DT transmembrane helix 1, which is conserved in anthrax lethal factor (LF), edema factor (EF), and botulinum neurotoxins A, C1, and D (5). Because the L221E mutation in the T1 motif in the diphtheria toxin-related...